hsa-miR-16

ncRNA information

ncRNA name

hsa-miR-16

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

BCL-2

Cancer information

Cancer name

Glioma

Cancer site

Brain, Central Nervous System

Treatment information

Treatment type

Chemotherapy

Drug

Temozolomide

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

The mimics of miR-16 greatly decreased the sensitivity of U251MG/TR cells to temozolomide.

Tissue resource

human glioblastoma cell lines U-138MG

human glioblastoma cell lines A172

human glioblastoma cell lines LN382

human glioblastoma cell lines AM-38

human glioblastoma cell lines U-251MG

human glioblastoma cell lines KMG4

Experiment

qRT-PCR,Western blot


Institute

American Type Culture Collection

Biofavor company

Country

USA

China

Continent

Amercia

Asia